###### Strengths and limitations of this study

-   This paper probes into socioeconomic (SE) differences in site-specific cancer mortality, using employment and occupational group as measures of socioeconomic position (SEP), accounting for two other SEP indicators (education and housing conditions).

-   The findings are based on an exhaustive dataset including the total Belgian population within the economically active age range, which provides very rich information on sociodemographic as well as SE variables and mortality for a follow-up period of 11 years.

-   These administrative register data do not contain information on incidence or survival, nor on health behaviours, healthcare use or important aspects of the job (eg, occupational exposures, psychosocial factors).

Introduction {#s1}
============

In industrialised countries, life expectancy increased during the epidemiological transition, with the most important causes of death (COD) shifting from infectious to chronic diseases such as cancer.[@R1] This favourable longevity trend went together with an increase in socioeconomic (SE) health inequalities in general[@R2] and with cancer inequalities in particular.[@R4] According to the fundamental cause theory (FCT), inequalities result from the differential distribution of valuable resources that can be used to avoid adverse health outcomes.[@R2] This implies that SE inequalities in health will be larger for cancers that are more preventable, either by avoiding risk behaviour or by access to medical interventions,[@R3] than for less or non-preventable cancers.

SE inequalities in health are one of the most important challenges for public health policies. Therefore, it is crucial to thoroughly document these inequalities. Up till now, most studies assessing health inequalities have used only one indicator of socioeconomic position (SEP), most often educational attainment or material wealth. However, detailed research on occupational inequalities in site-specific cancer mortality is scarce[@R6] and even non-existent in Belgium. Yet, many studies have shown that, although these SEP indicators are strongly related, they may represent different aspects of SEP.[@R8] Therefore, it is important to establish the role of every single dimension of SEP for every cancer site separately.[@R9]

Hence, this paper probes into SE differences in site-specific cancer mortality, using employment and occupational group as measures of SEP, accounting for the other SEP indicators. By doing so, we aim to estimate the net association between employment and occupational group and site-specific cancer mortality in Belgium, which has not yet been studied. Our first research aim is to examine the magnitude of the association between site-specific cancer mortality and employment group, net of one's educational attainment and housing conditions. The second research aim is to assess whether among the employed group, occupational group is associated with site-specific cancer mortality, again net of education and housing conditions. Based on the FCT, we assume that we will observe inequalities by employment and occupational status, especially for the more preventable cancer sites.

Data and methods {#s2}
================

Design and study population {#s2a}
---------------------------

Data are derived from a record linkage between the Belgian censuses of 1991 and 2001 and register data on emigration and cause-specific mortality for the follow-up period 01/10/2001 to 31/12/2011. This unique population-based dataset includes information on mortality, emigration, COD, sociodemographic (SD) and SE variables of the total de jure population of Belgium.

All SD and SE variables are extracted from the 2001 census, apart from occupational status for which the 1991 census contains the most recent detailed information. All Belgian individuals who are alive at the 2001 census and who were within the economically active age range (25--65 years) at the census of 1991 are included in the study. For these individuals, we linked information on employment and occupational status, stemming from the 1991 census, irrespective of their employment status at the 2001 census. The study population includes 2 333 479 Belgian women of whom 49% are employed and 2 231 385 Belgian men of whom 80% are employed. Age is included as a time-varying covariate to account for age changes during the 11-year follow-up period. To do so, individual follow-up time is split into episodes of 5 years attained age groups using Lexis expansions.[@R13] Consequently, the age distribution of this population ranges from 35 to 85 years.

Variables {#s2b}
---------

All cancer sites representing at least 1% of the total cancer mortality are included. [Table 1](#T1){ref-type="table"} gives an overview of these cancer sites, the corresponding ICD-10 codes and the level of preventability. To classify the cancers by level of preventability, we apply the criteria used in Mackenbach's study:[@R14] amenability to behavioural change and to medical interventions. Cancer sites are amenable to behavioural change if the combined population attributable fraction of mortality for overweight and obesity, low fruit and vegetable intake, physical inactivity, unsafe sex, smoking and alcohol consumption was larger than 50% for the European population in the Global Burden of Disease and Risk Factors study.[@R15] Cancer sites are considered as amenable to medical interventions, if the 5-year relative survival rate for Belgian women and men in the EUROCARE project was higher than 70% between 2000 and 2007[@R16] and/or if effective screening is available in Belgium.[@R17]

###### 

Cancer sites by ICD-10 classification and level of preventability

                                          ICD-10\*             Preventable   
  --------------------------------------- -------------------- ------------- -----
  Malignant neoplasms of:                                                    
   Head and neck                          C00--C14, C30--C32   Yes           --
   Oesophagus                             C15                  Yes           Yes
   Stomach                                C16                  Yes           No
   Colorectum and anus                    C18--C21             Yes           Yes
   Liver                                  C22                  Yes           No
   Pancreas                               C25                  No            No
   Lung, bronchus and trachea             C33--C34             Yes           Yes
   Breast                                 C50                  --            Yes
   Cervix uteri                           C53                  --            Yes
   Uterus                                 C54--C55             --            Yes
   Ovary                                  C56                  --            No
   Prostate                               C61                  Yes           --
   Kidney                                 C64--C66, C68        No            No
   Bladder                                C67                  Yes           Yes
  Eye, brain and central nervous system   C69--C72             No            No
  Malignant melanoma                      C43--C44             Yes           Yes
  Non-Hodgkin's lymphoma                  C82--C85             No            No
  Multiple myeloma                        C90                  No            No
  Leukaemia                               C91--C95             No            No

The empty cells are cancer sites not included for either men or women.

\* International Classification of Diseases and Related Health Problems - Tenth Revision

This study probes into cancer mortality inequality among the Belgian population within the economically active age range by using employment and occupational group as a measure of SEP. Both employment and occupational status are derived from the 1991 census and mortality is followed up for the period 2001--2011. Employment status is divided in four categories: employed, unemployed and looking for a job, unemployed and not looking for a job and disabled. Among the employed, we additionally defined their occupational group, based on the International Standard Classification of Occupations (see [table 2](#T2){ref-type="table"}):[@R18] managers and professionals, intermediate white-collar workers, service and sales workers, agricultural and fishery workers, skilled manual workers and unskilled manual workers. We choose the employed as a reference category and among the employed the managers and professionals. These choices have been made because of the size of these groups and because we assume lower cancer mortality for these groups, which facilitates the interpretation.

###### 

Description of the study population

  ISCO\*   Occupational status                    Men         Women                
  -------- -------------------------------------- ----------- -------- ----------- --------
           Disabled                               37 286      2235     26 905      824
           Unemployed and not looking for a job   295 674     21 704   924 226     25 953
           Employed and looking for a job         121 757     4418     235 766     2931
           Employed                               1 776 668   34 732   1 146 582   11 943
  1--2     Managers and professionals             452 268     8529     339 663     3512
  3--4     Intermediate white-collar workers      432 803     8114     384 478     3761
  5        Service and sales workers              92 369      1837     167 625     1670
  6        Agricultural and fishery workers       52 529      1352     17 303      282
  7--8     Skilled manual workers                 556 418     10 990   87 631      858
  9        Unskilled manual workers               163 433     3560     147 887     1848
           Missing                                26 848      350      1995        12

\* International Standard Classification of Occupations.

Statistical analyses {#s2c}
--------------------

To obtain a full picture of inequalities in cancer mortality, we calculate both absolute and relative measures,[@R19] using complete-case analysis. First, directly age-standardised site-specific mortality rates by employment and occupational group are calculated, using the Belgian population at the 2001 census as standard population. Second, mortality rate ratios (MRR) are calculated using Poisson's regression. We aim to assess the net effect of employment and occupational group on cancer mortality. Therefore, the Poisson's models are adjusted for educational attainment and housing conditions. Educational attainment is categorised using the International Standard Classification of Education: lower secondary education or less (ISCED 0--2, 'low'), higher secondary education (ISCED 3--4, 'mid') and tertiary education (ISCED 5--6, 'high'). Housing conditions is the result of a combination of ownership (tenant or owner) and comfort of the house (low-comfort, mid-comfort and high-comfort), resulting in six categories.[@R20] Sensitivity analyses are additionally conducted without adjustment for education and housing conditions. These results are not shown but are available in online [supplementary table 1 and 2](#SP1){ref-type="supplementary-material"}. Important differences between the crude and net model are mentioned in the discussion section. As there is a strong association in Belgium between mortality and region[@R21] as well as migration history,[@R22] all Poisson's models are adjusted for region (Flanders, Wallonia and Brussels) and migrant background (native vs non-native). All analyses are stratified by sex and are performed using STATA 13.1.

10.1136/bmjopen-2016-015216.supp1

Results {#s3}
=======

Description of the study population {#s3a}
-----------------------------------

The study population consists of almost 5 million Belgians within the economically active age range ([table 2](#T2){ref-type="table"}). Almost four out of five men are employed, whereas in women about one in two has a paid job.

Absolute cancer mortality rates by employment and occupational status {#s3b}
---------------------------------------------------------------------

For almost all preventable cancer sites, men belonging to the employed category have systematically the lowest cancer mortality rates ([table 3](#T3){ref-type="table"}). Among the employed men, white-collar workers and agricultural and fishery workers have lower cancer mortality rates compared with manual workers ([table 4](#T4){ref-type="table"}). These results hold true for all preventable cancer sites, except for prostate cancer and malignant melanoma for which no inequality is observed. For the non-preventable cancer sites, less inequalities are observed, as expected based on the FCT. For the non-preventable cancer sites, inequalities generally represent differences between employed versus unemployed.

###### 

Absolute site-specific cancer mortality rates (and 95% CI) (2001--2011) among the Belgian population within the economically active age range, by employment group in 1991

  Men                       Employed                 Unemployed and looking for a job       Unemployed and not looking for a job       Disabled
  ------------------------- ------------------------ -------------------------------------- ------------------------------------------ ------------------------
  All cancers               256.9 (253.8 to 260.0)   436.4 (423.0 to 449.9)                 380.2 (368.6 to 391.9)                     484.3 (462.7 to 506.0)
  Preventable cancers                                                                                                                  
   Head and neck            11.7 (11.2 to 12.3)      38.6 (34.7 to 42.4)                    24.8 (20.8 to 28.7)                        31.3 (25.0 to 37.6)
   Oesophagus               10.3 (9.7 to 10.9)       20.9 (18.0 to 23.7)                    12.8 (10.4 to 15.2)                        15.9 (11.9 to 19.9)
   Stomach                  8.2 (7.7 to 8.8)         11.9 (9.7 to 14.2)                     14.5 (12.0 to 17.0)                        17.0 (12.9 to 21.0)
   Colorectal               25.8 (24.8 to 26.8)      30.4 (26.8 to 34.0)                    34.3 (30.9 to 37.6)                        33.3 (27.9 to 38.8)
   Liver                    7.8 (7.2 to 8.3)         12.5 (10.3 to 14.7)                    10.8 (8.6 to 13.0)                         13.5 (9.8 to 17.3)
   Lung                     88.8 (87.0 to 90.6)      173.1 (164.6 to 181.7)                 148.8 (141.6 to 156.0)                     195.0 (181.6 to 208.3)
   Prostate                 17.2 (16.3 to 18.1)      17.3 (14.4 to 20.2)                    19.1 (17.6 to 20.6)                        27.9 (23.3 to 32.4)
   Bladder                  8.1 (7.5 to 8.7)         14.5 (12.0 to 17.1)                    11.8 (10.3 to 13.4)                        19.5 (15.2 to 23.8)
   Malignant melanoma       3.0 (2.7 to 3.3)         3.4 (2.2 to 4.5)                       1.9 (1.2 to 2.6)                           3.3 (1.2 to 5.3)
  Non-preventable cancers                                                                                                              
   Pancreas                 13.5 (12.8 to 14.3)      18.3 (15.5 to 21.1)                    15.4 (13.3 to 17.4)                        21.3 (16.5 to 26.1)
   Kidney                   7.8 (7.2 to 8.3)         8.1 (6.3 to 10.0)                      9.0 (7.3 to 10.8)                          12.2 (8.8 to 15.7)
   Eye, nervous system      7.3 (6.8 to 7.8)         6.9 (5.3 to 8.5)                       8.1 (6.2 to 10.1)                          10.4 (7.0 to 13.9)
   Non-Hodgkin              6.2 (5.7 to 6.7)         8.4 (6.5 to 10.3)                      6.9 (5.5 to 8.3)                           10.1 (6.7 to 13.5)
   Multiple myeloma         3.8 (3.4 to 4.2)         3.5 (2.3 to 4.6)                       4.0 (3.1 to 4.9)                           4.5 (2.4 to 6.6)
   Leukaemia                7.6 (7.0 to 8.2)         8.6 (6.6 to 10.6)                      10.1 (8.4 to 11.8)                         9.2 (6.4 to 12.0)
  **Women**                 **Employed**             **Unemployed and looking for a job**   **Unemployed and not looking for a job**   **Disabled**
  Cancer deaths             164.7 (160.0 to 169.4)   200.2 (181.6 to 218.9)                 187.5 (184.8 to 190.3)                     312.4 (286.7 to 338.1)
  Preventable cancers                                                                                                                  
   Oesophagus               3.3 (2.5 to 4.0)         3.0 (2.2 to 3.9)                       2.8 (2.5 to 3.1)                           4.7 (2.0 to 7.3)
   Colorectal               15.4 (14.0 to 16.8)      16.3 (11.6 to 20.9)                    18.5 (17.7 to 19.2)                        35.7 (26.6 to 44.7)
   Lung                     23.9 (22.2 to 25.7)      40.4 (31.6 to 49.3)                    28.7 (27.6 to 29.9)                        51.5 (41.1 to 61.9)
   Breast                   41.0 (38.8 to 43.1)      40.7 (33.4 to 47.9)                    42.4 (41.0 to 43.8)                        70.8 (58.3 to 83.3)
   Cervix                   2.8 (2.2 to 3.3)         7.3 (2.9 to 11.6)                      3.9 (3.4 to 4.4)                           3.8 (0.7 to 6.9)
   Uterus                   5.6 (4.6 to 6.6)         5.0 (3.9 to 6.1)                       6.1 (5.6 to 6.5)                           7.4 (3.9 to 10.9)
   Bladder                  1.6 (1.2 to 2.1)         2.9 (0.0 to 6.0)                       2.5 (2.2 to 2.8)                           7.6 (3.4 to 11.7)
   Malignant melanoma       2.5 (2.0 to 2.9)         3.8 (0.7 to 6.9)                       2.3 (2.0 to 2.6)                           1.9 (0.3 to 3.9)
  Non-preventable cancers                                                                                                              
   Stomach                  3.2 (2.6 to 3.9)         4.4 (1.3 to 7.5)                       4.4 (4.0 to 4.8)                           9.8 (4.7 to 14.8)
   Liver                    2.9 (2.3 to 3.5)         5.6 (1.3 to 9.9)                       4.6 (4.2 to 5.0)                           6.1 (2.7 to 9.5)
   Pancreas                 10.4(9.0 to 11.7)        8.3 (5.0 to 11.5)                      10.9 (10.3 to 11.5)                        14.5 (9.1 to 19.9)
   Ovary                    13.4 (12.0 to 14.7)      9.0 (7.6 to 10.5)                      12.4 (11.7 to 13.1)                        13.2 (8.1 to 18.3)
   Kidney                   2.8 (2.2 to 3.4)         5.8 (1.4 to 10.1)                      4.3 (3.9 to 4.7)                           6.8 (3.9 to 9.7)
   Eye, nervous system      5.3 (4.5 to 6.1)         5.4 (2.3 to 8.5)                       5.7 (5.2 to 6.3)                           11.1 (6.2 to 16.0)
   Non-Hodgkin              3.9 (3.1 to 4.7)         4.6 (1.5 to 7.8)                       4.6 (4.2 to 5.0)                           7.2 (2.7 to 11.8)
   Multiple myeloma         2.7 (2.0 to 3.4)         3.2 (0.1 to 6.3)                       3.3 (2.9 to 3.6)                           2.1 (0.2 to 4.0)
   Leukaemia                5.0 (4.1 to 5.9)         2.6 (1.8 to 3.4)                       5.3 (4.9 to 5.7)                           8.7 (3.9 to 13.6)

###### 

Absolute site-specific cancer mortality rates (and 95% CI) (2001--2011) among the Belgian employed population, by occupational group in 1991

  Men                       Managers and professionals   Intermediate white-collar   Service and sales workers   Agricultural and fishery workers   Skilled manual workers   Unskilled manual workers
  ------------------------- ---------------------------- --------------------------- --------------------------- ---------------------------------- ------------------------ --------------------------
  All cancers               163.3 (159.8 to 166.9)       190.0 (185.9 to 194.1)      232.3 (221.6 to 242.9)      177.6 (166.5 to 188.7)             228.4 (224.0 to 232.8)   246.3 (238.1 to 254.4)
  Preventable cancers                                                                                                                                                        
   Head and neck            8.2 (7.4 to 9.0)             10.1 (9.2 to 11.0)          14.7 (12.1 to 17.3)         9.8 (6.9 to 12.8)                  12.4 (11.4 to 13.3)      17.0 (14.9 to 19.1)
   Oesophagus               7.6 (6.9 to 8.4)             8.5 (7.6 to 9.3)            9.3 (7.2 to 11.4)           6.4 (4.2 to 8.7)                   9.4 (8.5 to 10.3)        10.2 (8.5 to 11.8)
   Stomach                  5.2 (4.6 to 5.8)             6.2 (5.4 to 6.9)            5.4 (3.8 to 7.1)            6.1 (4.1 to 8.1)                   7.9 (7.1 to 8.7)         8.3 (6.8 to 9.9)
   Colorectal               17.5 (16.4 to 18.6)          19.0 (17.7 to 20.3)         21.2 (17.9 to 24.4)         13.6 (10.6 to 16.5)                20.5 (19.1 to 21.8)      20.3 (17.9 to 22.7)
   Liver                    6.3 (5.6 to 7.0)             6.0 (5.2 to 6.7)            6.7 (4.9 to 8.5)            2.0 (0.8 to 3.2)                   5.5 (4.8 to 6.2)         7.0 (5.7 to 8.4)
   Lung                     48.0 (46.1 to 49.9)          62.8 (60.5 to 65.2)         84.8 (78.4 to 91.3)         65.1 (58.4 to 71.9)                91.1 (88.3 to 93.8)      97.1 (91.9 to 102.2)
   Prostate                 9.6 (8.8 to 10.4)            10.2 (9.2 to 11.2)          11.5 (9.0 to 13.9)          9.5 (7.3 to 11.7)                  10.6 (9.6 to 11.7)       11.4 (9.5 to 13.2)
   Bladder                  4.7 (4.1 to 5.3)             5.8 (5.1 to 6.6)            7.0 (5.1 to 8.9)            4.0 (2.4 to 5.5)                   6.0 (5.3 to 6.7)         8.2 (6.6 to 9.7)
   Malignant melanoma       2.9 (2.4 to 3.4)             2.7 (2.2 to 3.2)            3.8 (2.4 to 5.1)            3.0 (1.4 to 4.6)                   2.4 (2.0 to 2.8)         2.2 (1.4 to 2.9)
  Non-preventable cancers                                                                                                                                                    
   Pancreas                 10.7 (9.8 to 11.6)           10.2 (9.2 to 11.2)          11.6 (9.2 to 14.0)          10.3 (7.5 to 13.0)                 10.1 (9.1 to 11.0)       11.0 (9.3 to 12.8)
   Kidney                   5.5 (4.9 to 6.2)             6.2 (5.5 to 7.0)            6.0 (4.3 to 7.7)            5.4 (3.6 to 7.3)                   6.0 (5.3 to 6.7)         5.4 (4.2 to 6.6)
   Eye, nervous system      6.5 (5.8 to 7.3)             6.8 (6.0 to 7.5)            6.9 (5.1 to 8.7)            5.3 (3.3 to 7.3)                   6.2 (5.5 to 6.9)         6.0 (4.7 to 7.2)
   Non-Hodgkin              4.6 (4.0 to 5.1)             4.5 (3.9 to 5.1)            5.3 (3.7 to 6.9)            6.7 (4.4 to 9.0)                   4.8 (4.2 to 5.5)         3.5 (2.5 to 4.5)
   Multiple myeloma         2.5 (2.1 to 3.0)             3.0 (2.5 to 3.5)            2.5 (1.3 to 3.6)            3.4 (1.9 to 4.9)                   2.6 (2.1 to 3.0)         3.1 (2.2 to 4.0)
   Leukaemia                4.9 (4.3 to 5.5)             5.2 (4.5 to 5.9)            6.7 (4.9 to 8.5)            6.0 (4.1 to 7.9)                   5.5 (4.8 to 6.2)         5.7 (4.5 to 7.0)

  Women                     Managers and professionals   Intermediate white-collar   Service and sales workers   Agricultural and fishery workers   Skilled manual workers   Unskilled manual workers
  ------------------------- ---------------------------- --------------------------- --------------------------- ---------------------------------- ------------------------ --------------------------
  Cancer deaths             98.2 (95.0 to 101.5)         106.1 (102.7 to 109.6)      101.9 (97.0 to 106.8)       92.9 (79.0 to 106.8)               107.7 (100.2 to 115.1)   111.1 (106.0 to 116.2)
   Preventable cancers                                                                                                                                                       
   Oesophagus               1.3 (0.9 to 1.6)             1.7 (1.3 to 2.2)            2.2 (1.4 to 2.9)            1.5 (0.0 to 3.2)                   1.2 (0.4 to 2.0)         1.8 (1.1 to 2.4)
   Colorectal               8.3 (7.3 to 9.2)             9.9 (8.8 to 11.0)           8.6 (7.2 to 10.0)           5.6 (2.5 to 8.7)                   11.4 (9.0 to 13.8)       8.3 (6.9 to 9.6)
   Lung                     13.5 (12.3 to 14.7)          16.5 (15.2 to 17.8)         17.9 (15.9 to 20.0)         8.6 (4.5 to 12.8)                  17.2 (14.3 to 20.1)      22.2 (19.9 to 24.5)
   Breast                   30.3 (28.5 to 32.1)          32.1 (30.2 to 33.9)         26.6 (24.1 to 29.1)         28.9 (20.6 to 37.3)                30.1 (26.2 to 33.9)      27.7 (25.1 to 30.3)
   Cervix                   1.9 (1.4 to 2.3)             1.8 (1.4 to 2.3)            2.6 (1.8 to 3.3)            1.4 (0.0 to 3.1)                   1.9 (0.9 to 2.8)         3.0 (2.1 to 3.9)
   Uterus                   2.4 (1.9 to 2.9)             2.6 (2.0 to 3.1)            3.3 (2.4 to 4.2)            1.6 (0.4 to 2.8)                   3.7 (2.1 to 5.2)         2.0 (1.4 to 2.7)
   Bladder                  0.8 (0.5 to 1.1)             0.8 (0.5 to 1.1)            1.1 (0.6 to 1.6)            0.5 (0.0 to 1.2)                   0.9 (0.2 to 1.7)         1.0 (0.5 to 1.5)
   Malignant melanoma       1.8 (1.4 to 2.3)             2.1 (1.6 to 2.6)            1.7 (1.0 to 2.3)            3.0 (0.2 to 5.7)                   2.3 (1.3 to 3.4)         2.3 (1.5 to 3.0)
  Non-preventable cancers                                                                                                                                                    
   Stomach                  1.6 (1.2 to 2.0)             1.8 (1.3 to 2.2)            1.8 (1.2 to 2.5)            5.4 (1.8 to 9.0)                   2.2 (1.1 to 3.3)         3.1 (2.3 to 4.0)
   Liver                    1.4 (1.0 to 1.8)             1.5 (1.1 to 1.9)            1.7 (1.1 to 2.3)            1.4 (0.0 to 2.9)                   1.5 (0.6 to 2.4)         2.1 (1.4 to 2.8)
   Pancreas                 5.5 (4.7 to 6.3)             5.2 (4.4 to 5.9)            5.5 (4.4 to 6.7)            3.1 (1.5 to 4.8)                   4.8 (3.2 to 6.4)         5.6 (4.5 to 6.8)
   Ovary                    7.4 (6.5 to 8.3)             7.2 (6.3 to 8.1)            7.0 (5.7 to 8.2)            10.4 (6.0 to 14.9)                 8.5 (6.4 to 10.6)        8.3 (6.9 to 9.7)
   Kidney                   1.9 (1.4 to 2.3)             1.5 (1.1 to 2.0)            1.8 (1.2 to 2.5)            1.7 (0.0 to 3.4)                   1.6 (0.7 to 2.5)         1.5 (1.0 to 2.1)
   Eye, nervous system      4.1 (3.4 to 4.8)             3.5 (2.9 to 4.1)            3.6 (2.7 to 4.5)            4.2 (0.8 to 7.5)                   3.3 (2.1 to 4.5)         4.1 (3.2 to 5.1)
   Non-Hodgkin              1.8 (1.3 to 2.2)             2.2 (1.7 to 2.7)            1.9 (1.3 to 2.6)            1.7 (0.0 to 3.5)                   2.8 (1.6 to 4.0)         2.0 (1.3 to 2.7)
   Multiple myeloma         1.2 (0.8 to 1.5)             1.3 (0.9 to 1.7)            1.2 (0.7 to 1.7)            2.6 (0.0 to 5.5)                   1.0 (0.2 to 1.7)         1.2 (0.6 to 1.7)
   Leukaemia                2.4 (1.9 to 2.9)             2.6 (2.0 to 3.1)            2.6 (1.8 to 3.4)            2.9 (0.4 to 5.5)                   3.3 (1.9 to 4.8)         2.8 (2.0 to 3.7)

For women, the absolute inequalities are less pronounced. Generally, mortality from preventable cancer sites is largest for women who are unemployed ([table 3](#T3){ref-type="table"}). Among the employed women there are no inequalities, except for lung cancer mortality which is somewhat more elevated for service and sales workers and manual workers compared with female managers ([table 4](#T4){ref-type="table"}). On the other hand, service and sales workers have a lower breast cancer mortality rate compared with intermediate white-collar workers. Neither do we observe an occupational inequality pattern for mortality from non-preventable cancer sites. The only exception is stomach cancer mortality, which is highest among the unskilled manual workers.

Relative cancer mortality inequality by employment and occupational status {#s3c}
--------------------------------------------------------------------------

In this paragraph, we present the results of the net relative models, adjusted for education and housing conditions. Unemployed men and women have higher site-specific cancer mortality rates compared with employed people ([table 5](#T5){ref-type="table"}). This holds true for preventable and non-preventable cancers and are especially observed among the unemployed who are not looking for a job. To illustrate this with an example: unemployed men who are not looking for a job have a three times higher chance of dying from bladder cancer (MRR 3.37; 95% CI 3.05 to 3.73) compared with employed men. For most cancer sites (mainly the preventable cancers) particularly unemployed men and women who are either not looking for a job or disabled have consistently higher cancer mortality rates compared with employed men and women.

###### 

Net relative site-specific cancer mortality inequality (mortality rate ratios and 95% CI) (2001--2011) among the Belgian population within the economically active age range, by employment group in 1991

  Men                       Employed       Unemployed and looking for a job       Unemployed and not looking for a job       Disabled                             
  ------------------------- -------------- -------------------------------------- ------------------------------------------ -------------- -------------- ------ --------------
  All cancers               1.00           1.60                                   1.55 to 1.65                               2.74           2.69 to 2.80   2.28   2.19 to 2.37
  Preventable cancers                                                                                                                                             
   Head and neck            1.00           2.33                                   2.10 to 2.59                               2.73           2.46 to 3.02   2.18   1.80 to 2.65
   Oesophagus               1.00           2.09                                   1.83 to 2.38                               2.36           2.12 to 2.62   1.98   1.59 to 2.48
   Stomach                  1.00           1.35                                   1.13 to 1.61                               2.97           2.68 to 3.30   2.65   2.15 to 3.28
   Colorectal               1.00           1.26                                   1.14 to 1.41                               2.61           2.45 to 2.77   1.71   1.48 to 1.99
   Liver                    1.00           1.49                                   1.25 to 1.76                               2.31           2.06 to 2.60   2.29   1.82 to 2.88
   Lung                     1.00           1.71                                   1.63 to 1.79                               2.86           2.77 to 2.95   2.52   2.37 to 2.69
   Prostate                 1.00           1.17                                   1.01 to 1.35                               2.78           2.59 to 2.99   2.30   1.96 to 2.70
   Bladder                  1.00           1.91                                   1.62 to 2.25                               3.37           3.05 to 3.73   2.65   2.13 to 3.29
   Malignant melanoma       1.00           1.30                                   0.97 to 1.73                               1.90           1.57 to 2.31   1.05   0.59 to 1.88
  Non-preventable cancers                                                                                                                                         
   Pancreas                 1.00           1.38                                   1.21 to 1.58                               2.44           2.24 to 2.66   1.85   1.53 to 2.25
   Kidney                   1.00           1.18                                   0.97 to 1.45                               2.39           2.14 to 2.68   2.52   2.01 to 3.16
   Eye, nervous system      1.00           0.94                                   0.75 to 1.17                               2.14           1.88 to 2.44   2.15   1.64 to 2.82
   Non-Hodgkin              1.00           1.35                                   1.09 to 1.66                               2.42           2.13 to 2.75   1.79   1.33 to 2.43
   Multiple myeloma         1.00           1.25                                   0.93 to 1.68                               2.86           2.46 to 3.32   1.48   0.97 to 2.25
   Leukaemia                1.00           1.05                                   0.84 to 1.31                               2.73           2.44 to 3.06   1.72   1.30 to 2.28
  **Women**                 **Employed**   **Unemployed and looking for a job**   **Unemployed and not looking for a job**   **Disabled**                         
  Cancer deaths             1.00           1.11                                   1.07 to 1.15                               1.74           1.71 to 1.78   1.96   1.83 to 2.09
   Preventable cancers                                                                                                                                            
   Oesophagus               1.00           1.35                                   1.04 to 1.75                               1.67           1.40 to 1.99   1.94   1.15 to 3.26
   Colorectal               1.00           1.09                                   0.97 to 1.23                               1.79           1.68 to 1.92   2.23   1.83 to 2.73
   Lung                     1.00           1.19                                   1.10 to 1.29                               1.61           1.53 to 1.70   1.82   1.54 to 2.14
   Breast                   1.00           1.02                                   0.95 to 1.09                               1.64           1.57 to 1.71   1.93   1.68 to 2.22
   Cervix                   1.00           1.78                                   1.45 to 2.18                               1.85           1.57 to 2.19   0.90   0.42 to 1.91
   Uterus                   1.00           1.36                                   1.11 to 1.67                               2.12           1.86 to 2.40   1.83   1.22 to 2.75
   Bladder                  1.00           1.07                                   0.73 to 1.56                               1.99           1.63 to 2.43   3.20   1.92 to 5.34
   Malignant melanoma       1.00           1.02                                   0.79 to 1.32                               1.35           1.14 to 1.59   1.09   0.54 to 2.21
  Non-preventable cancers                                                                                                                                         
   Stomach                  1.00           1.03                                   0.81 to 1.31                               1.70           1.48 to 1.96   2.26   1.50 to 3.40
   Liver                    1.00           1.10                                   0.84 to 1.44                               2.31           1.99 to 2.68   1.63   0.98 to 2.70
   Pancreas                 1.00           0.94                                   0.80 to 1.11                               1.76           1.61 to 1.92   1.65   1.23 to 2.22
   Ovary                    1.00           0.99                                   0.86 to 1.14                               1.56           1.44 to 1.69   1.13   0.82 to 1.56
   Kidney                   1.00           1.21                                   0.93 to 1.57                               2.04           1.76 to 2.35   3.33   2.28 to 4.87
   Eye, nervous system      1.00           0.79                                   0.64 to 0.98                               1.61           1.43 to 1.80   1.39   0.89 to 2.18
   Non-Hodgkin              1.00           0.99                                   0.76 to 1.29                               1.96           1.70 to 2.25   1.54   0.95 to 2.52
   Multiple myeloma         1.00           0.93                                   0.65 to 1.34                               2.33           1.96 to 2.77   1.32   0.65 to 2.69
   Leukaemia                1.00           0.75                                   0.57 to 0.97                               1.66           1.46 to 1.88   1.35   0.85 to 2.15

Reference category is employed.

All analyses are adjusted for current age, region, migrant background, educational attainment and housing conditions.

Within the employed population, inequalities by occupation are also observed although more in men than in women ([table 6](#T6){ref-type="table"}). In men, managers appear to have higher colorectal and liver cancer mortality rates compared with men in other occupations. Furthermore, lower mortality rates in favour of manual workers are observed for several non-preventable cancer sites, among others cancer of the pancreas and kidney. Compared with male managers, skilled manual workers have a 7% higher lung cancer mortality rate. Another interesting observation is the mortality pattern of the agricultural and fishery workers. Compared with managers, they tend to die less from preventable cancers such as head and neck and oesophageal cancers. Their liver cancer mortality rate is even 76% lower compared with managers (MRR 0.24; 95% CI 0.15 to 0.39). In contrast, agricultural and fishery workers show higher mortality from some non-preventable cancer sites such as leukaemia and multiple myeloma. Female manual workers and service and sales workers have about 25% lower breast cancer mortality rates compared with female managers.

###### 

Net relative site-specific cancer mortality inequality (mortality rate ratios and 95% CI) (2001--2011) among the Belgian employed population, by occupational group in 1991

  Men                       Managers and professionals   Intermediate white-collar   Service and sales workers   Agricultural and fishery workers   Skilled manual workers   Unskilled manual workers                                               
  ------------------------- ---------------------------- --------------------------- --------------------------- ---------------------------------- ------------------------ -------------------------- -------------- ------ -------------- ------ --------------
  All cancers               1.00                         0.93                        0.91 to 0.96                0.95                               0.91 to 0.99             0.93                       0.88 to 0.97   0.9    0.87 to 0.93   0.94   0.90 to 0.97
  Preventable cancers                                                                                                                                                                                                                               
   Head and neck            1.00                         0.92                        0.82 to 1.04                1.03                               0.86 to 1.23             0.67                       0.52 to 0.88   0.83   0.73 to 0.95   1.13   0.98 to 1.32
   Oesophagus               1.00                         0.9                         0.80 to 1.01                0.84                               0.68 to 1.04             0.66                       0.50 to 0.87   0.83   0.73 to 0.95   0.87   0.73 to 1.04
   Stomach                  1.00                         0.98                        0.85 to 1.13                0.88                               0.68 to 1.14             0.99                       0.74 to 1.33   0.99   0.84 to 1.16   1.03   0.84 to 1.27
   Colorectal               1.00                         0.89                        0.82 to 0.97                0.8                                0.69 to 0.93             0.8                        0.68 to 0.94   0.79   0.72 to 0.86   0.83   0.73 to 0.94
   Liver                    1.00                         0.73                        0.63 to 0.84                0.54                               0.41 to 0.72             0.24                       0.15 to 0.39   0.56   0.48 to 0.65   0.64   0.52 to 0.79
   Lung                     1.00                         0.97                        0.93 to 1.02                1.04                               0.97 to 1.12             0.98                       0.90 to 1.07   1.07   1.02 to 1.12   1.05   0.99 to 1.12
   Prostate                 1.00                         0.87                        0.78 to 0.97                0.83                               0.68 to 1.01             1.11                       0.92 to 1.34   0.75   0.67 to 0.85   0.86   0.73 to 1.01
   Bladder                  1.00                         0.93                        0.79 to 1.08                0.94                               0.72 to 1.22             0.74                       0.54 to 1.01   0.85   0.72 to 1.00   1.08   0.88 to 1.34
   Malignant melanoma       1.00                         0.86                        0.70 to 1.04                1.11                               0.81 to 1.53             1.11                       0.76 to 1.62   0.53   0.42 to 0.66   0.62   0.45 to 0.84
  Non-preventable cancers                                                                                                                                                                                                                           
   Pancreas                 1.00                         0.88                        0.79 to 0.98                0.84                               0.69 to 1.01             0.94                       0.76 to 1.15   0.74   0.66 to 0.83   0.78   0.67 to 0.92
   Kidney                   1.00                         0.94                        0.82 to 1.08                0.85                               0.66 to 1.10             0.85                       0.64 to 1.14   0.77   0.66 to 0.90   0.64   0.51 to 0.81
   Eye, nervous system      1.00                         0.93                        0.81 to 1.06                0.87                               0.69 to 1.11             0.93                       0.70 to 1.23   0.7    0.61 to 0.82   0.7    0.56 to 0.87
   Non-Hodgkin              1.00                         0.85                        0.73 to 1.00                1                                  0.76 to 1.31             1.32                       0.99 to 1.76   0.83   0.69 to 0.99   0.72   0.55 to 0.93
   Multiple myeloma         1.00                         1.09                        0.90 to 1.34                0.69                               0.44 to 1.07             1.55                       1.09 to 2.22   0.82   0.65 to 1.04   0.9    0.65 to 1.25
   Leukaemia                1.00                         0.95                        0.81 to 1.11                1.13                               0.87 to 1.47             1.33                       1.01 to 1.74   0.9    0.76 to 1.07   0.95   0.75 to 1.20

  Women                     Managers and professionals   Intermediate white-collar   Service and sales workers   Agricultural and fishery workers   Skilled manual workers   Unskilled manual workers                                               
  ------------------------- ---------------------------- --------------------------- --------------------------- ---------------------------------- ------------------------ -------------------------- -------------- ------ -------------- ------ --------------
  Cancer deaths             1.00                         0.89                        0.86 to 0.93                0.79                               0.75 to 0.83             0.91                       0.82 to 1.02   0.77   0.72 to 0.82   0.83   0.79 to 0.88
  Preventable cancers                                                                                                                                                                                                                               
   Oesophagus               1.00                         0.86                        0.60 to 1.22                1.02                               0.66 to 1.59             0.94                       0.39 to 2.25   0.56   0.29 to 1.07   0.95   0.60 to 1.52
   Colorectal               1.00                         1.00                        0.88 to 1.15                0.84                               0.70 to 1.01             0.66                       0.43 to 1.01   1.04   0.85 to 1.29   0.86   0.71 to 1.03
   Lung                     1.00                         0.89                        0.80 to 0.99                0.82                               0.72 to 0.94             0.48                       0.33 to 0.70   0.78   0.66 to 0.92   0.86   0.75 to 0.98
   Breast                   1.00                         0.93                        0.86 to 1.00                0.74                               0.67 to 0.82             1.03                       0.84 to 1.27   0.75   0.66 to 0.85   0.75   0.67 to 0.84
   Cervix                   1.00                         0.79                        0.57 to 1.08                0.78                               0.53 to 1.15             0.44                       0.14 to 1.41   0.54   0.33 to 0.88   0.8    0.55 to 1.18
   Uterus                   1.00                         0.91                        0.70 to 1.19                1.07                               0.78 to 1.47             0.68                       0.32 to 1.42   0.91   0.59 to 1.42   0.7    0.48 to 1.02
   Bladder                  1.00                         0.93                        0.59 to 1.47                1.68                               0.95 to 2.98             1.69                       0.57 to 4.97   1.61   0.81 to 3.22   1.48   0.78 to 2.81
   Malignant melanoma       1.00                         1.07                        0.81 to 1.40                0.68                               0.45 to 1.03             0.76                       0.31 to 1.88   0.95   0.61 to 1.47   1.03   0.72 to 1.49
  Non-preventable cancers                                                                                                                                                                                                                           
   Stomach                  1.00                         1.03                        0.76 to 1.41                0.9                                0.61 to 1.35             1.68                       0.87 to 3.21   0.87   0.52 to 1.43   1.67   1.16 to 2.40
   Liver                    1.00                         0.78                        0.56 to 1.10                0.64                               0.41 to 0.99             0.27                       0.06 to 1.14   0.71   0.40 to 1.24   1.07   0.72 to 1.59
   Pancreas                 1.00                         0.8                         0.67 to 0.95                0.76                               0.61 to 0.96             0.82                       0.52 to 1.31   0.72   0.53 to 0.98   0.89   0.70 to 1.12
   Ovary                    1.00                         0.76                        0.65 to 0.88                0.79                               0.64 to 0.96             1.63                       1.20 to 2.21   0.82   0.64 to 1.04   0.79   0.64 to 0.97
   Kidney                   1.00                         0.54                        0.39 to 0.74                0.7                                0.47 to 1.03             1.04                       0.52 to 2.09   0.59   0.36 to 0.98   0.62   0.41 to 0.94
   Eye, nervous system      1.00                         0.73                        0.59 to 0.90                0.8                                0.62 to 1.05             1.16                       0.69 to 1.95   0.71   0.50 to 1.00   0.72   0.53 to 0.97
   Non-Hodgkin              1.00                         1.01                        0.75 to 1.35                0.78                               0.53 to 1.15             1.33                       0.69 to 2.59   1.09   0.69 to 1.72   0.82   0.56 to 1.21
   Multiple myeloma         1.00                         0.98                        0.70 to 1.38                0.91                               0.57 to 1.45             0.77                       0.27 to 2.17   0.71   0.35 to 1.43   0.8    0.49 to 1.30
   Leukaemia                1.00                         0.87                        0.68 to 1.12                0.75                               0.53 to 1.07             0.89                       0.47 to 1.69   0.77   0.51 to 1.18   0.89   0.64 to 1.24

Reference category is managers and professionals.

All analyses are adjusted for current age, region, migrant background, educational attainment and housing conditions.

Discussion and conclusion {#s4}
=========================

Methodological issues {#s4a}
---------------------

The findings are based on a high-quality and exhaustive dataset including the total Belgian population within the economically active age range. A numerator--denominator bias was eliminated through record linkage between census and register data. This dataset provides very rich information on SD as well as SE variables and mortality for a follow-up period of 11 years. This enables us to give precise estimates of site-specific cancer mortality inequalities at the individual level. However, these register data do not contain information on incidence or survival, nor on health behaviours, healthcare use or important aspects of the job (eg, occupational exposures, psychosocial factors), which are all likely to be associated with cancer outcomes.[@R23] Therefore, it is difficult to make solid conclusions on the relative importance of all these factors to explain the observed SE inequalities in cancer mortality.[@R23]

We included the total Belgian population that belonged to the economically active age group (25--65 years) at the census of 1991, independently of their actual occupational status. We decided so because we were interested in the association between cancer mortality and both employment and occupational group. By doing so, we avoided a selection effect due to including only the healthy workers.[@R6] Our results indicate the importance of this issue, showing highest (site-specific) cancer mortality among the unemployed groups. Nevertheless, we cannot fully exclude a selection effect among the employed population because we can assume that unhealthy persons are less frequently employed in physically demanding jobs.[@R26] A healthy worker effect might then be more likely in the groups of manual workers, which could partly explain some of the observed mortality patterns in favour of manual workers. On the other hand, the white-collar workers may have less physically demanding jobs, which can counter this effect. Occupational information was derived from the census of 1991, which is the most recent source of detailed information since the census of 2001 does not contain detailed occupational information. Because of the lag time between some (occupational) exposures and cancer mortality, we do not consider this as a problem.[@R29] Due to the cross-sectional nature of this information, the occupation is not necessarily the longest job respondents were involved in nor do we have information on the duration of this occupation.[@R25] However, occupation was grouped into broad groups, which leads us to assume that the bias due to transitions between occupational categories will be rather small.[@R30]

We decided not to use the robust distinction between manual versus non-manual workers nor did we focus on one specific cancer site in relation to one or more job exposures. These choices have been made in order to gain insights into the overall association between occupational status and cancer mortality.[@R26] Many studies assessing SE inequalities in cancer mortality use only one SE indicator at a time although the importance of including multiple indicators has already been pointed out[@R9] because different SEP indicators tap into different pathways.[@R8] Housing conditions are related to material and financial resources and therefore to healthcare utilisation.[@R31] Education captures the human capital acquired early in life and may be related to the ability to adapt health education messages and hence to health behaviours.[@R6] Occupational status on the other hand reflects the ability to realise this human capital in the labour market and is rather a reflection of one's social class at older ages. Employment as well as occupation is likely to (partially) capture material resources, access to healthcare as well as social networks and work-related factors such as stress, autonomy and occupational hazards. Hence, we need to analyse all aspects of SEP in relation to health outcomes, although these indicators are closely related.[@R6] In this paper, we focus on the net effect of occupational status, thereby adjusting for educational attainment and housing conditions. The results indicate an association between occupational status and site-specific cancer mortality, independently of education and housing conditions.

Finally, we classified the cancer sites by their level of preventability (see Methods section). We acknowledge that this classification does not exclude the fact that some 'non-preventable' cancers are also related to behavioural change and/or medical interventions nor does it eliminate some possible overlap between these two criteria of preventability. However, to enhance the comparability with other studies, we decided to adopt this often-used classification.

Theoretical considerations on the main findings {#s4b}
-----------------------------------------------

This study reveals inequalities in site-specific cancer mortality by employment and occupational groups. Generally SE inequalities are less pronounced in women compared with men, which is consistent with the literature.[@R7] The unemployed group (and especially those not looking for a job) shows both for men and women higher cancer mortality rates compared with the employed, which is in line with previous studies in France and the UK.[@R23] Possible explanations are financial insecurity, which is related to a lower use of healthcare services and an unhealthy lifestyle.[@R32] Some studies suggest that part of this association between unemployment and health might be due to health selection,[@R23] although others observed an ongoing effect after adjustment for pre-existing morbidity.[@R32] However, it is very likely that for the unemployed that are not looking for a job, as well as for the disabled group, health selection will be at play.

Also within the employed group, inequalities by occupational group are observed. In men, these findings are in line with the FCT which expects larger inequalities for more preventable cancer sites.[@R3] The absolute results show that male manual workers have the highest site-specific cancer mortality rates whereas white-collar workers and agricultural and fishery workers have the lowest cancer mortality rates. This discrepancy between manual and non-manual workers is in line with previous findings in Europe.[@R6] These absolute inequalities are manifest for all preventable cancer sites (except for non-malignant melanoma and prostate cancer), with alcohol-related and smoking-related cancers (eg, cancers of the lung, head and neck and bladder) being the main contributors to these inequalities, as reported in previous studies.[@R25] The excess mortality for cancers of the head and neck and lung are also observed for male service and sales workers, which can be explained by the higher likelihood of occupational exposure to tobacco and alcohol in bars and restaurants.[@R27] Another interesting finding is the favourable cancer mortality pattern for farmers, which might be related to their healthy life style with less tobacco and alcohol use and more physical activity.[@R35]

According to the FCT, the availability of valuable resources such as knowledge, money, power, prestige and beneficial social connections are the social causes of health inequalities.[@R2] When there is sound knowledge of the causes and cures of cancers, those in high SEP contexts, with greater access to resources, will disproportionally benefit from this knowledge. Several mechanisms have been suggested to explain this association, such as a differential acquisition of knowledge on health-damaging behaviours (eg, smoking, bad diet, alcohol intake or a lack of exercise).[@R6] Also, material factors are important: having financial difficulties might be related to poor living conditions[@R7] or the inability to optimise the use of health services.[@R10] Both access to and quality of healthcare are crucial for health outcomes in all stages, from prevention (eg, through cancer screening) to treatment. Finally, the social aspect of SEP is associated with health, for example stress-related factors or the level of social prestige.[@R25] Since we cannot adjust for health behaviours or healthcare use, it remains difficult to decide on the extent of inequalities due to each of these mechanisms.[@R26] Yet, our findings showed that the inequalities were especially large for the preventable cancer sites related to health behaviours such as smoking and alcohol use. Previous studies indeed reported higher smoking prevalence among manual workers and people working in the catering industry.[@R38] However, studies mediating the observed gradients for smoking reported an attenuated but still significant relation between SEP and mortality,[@R7] which assumes that there might be other factors at play as well. Sensitivity analyses not adjusting for education and housing conditions showed both for men and women lowest lung cancer mortality among the managers compared with all other occupational groups (see online [Supplementary table 2](#SP1){ref-type="supplementary-material"}). However, in the models adjusted for education and housing conditions (presented in [table 6](#T6){ref-type="table"}), the association reversed for women, whereas for men lung cancer mortality only remains somewhat higher for male skilled manual workers, which could be related to occupational exposures. In contrary, in the adjusted model, higher breast cancer mortality rates were observed in female managers compared with all other occupations except sales and service workers. This can be explained by differences in reproductive behaviour, with less children and a later age at first birth for the white-collar occupations.[@R24] In the net model, male managers had higher colorectal and liver cancer mortality compared with all other occupations. Yet, in the unadjusted model, the association between occupation and colorectal cancer mortality disappeared (see online [supplementary table 2](#SP1){ref-type="supplementary-material"}). Moreover, compared with the white-collar occupations, manual workers do have lower mortality for several other cancer sites (eg, malignant melanoma and kidney). These results are counterintuitive, suggesting that there are other factors at play, such as an unhealthy and sedentary lifestyle of managers.[@R39]

We can assume that the results of the net model are more likely to be due to differences related to the job itself. Yet, a healthy lifestyle may be induced by the social environment (eg, the colleagues at work), and therefore might not be excluded as a potential mechanism.[@R6] Specific occupational exposures and hazards may explain part of the association between occupational status and health.[@R7] Another important aspect of work related to health is the psychosocial aspect of the job, such as the sense of control and autonomy, the level of job strain or long working hours.[@R7] This could be an explanation for the excessive colorectal cancer mortality among male managers. Colorectal cancer is associated with perceived stress and could therefore be related to the long working hours and work strain as perceived by managers.[@R39]

Implications and conclusion {#s4c}
---------------------------

This paper highlights important SE inequalities in site-specific cancer mortality by employment and occupational groups. Being unemployed, and among the employed, being employed as a manual worker or service and sales worker is associated with higher overall and site-specific cancer mortality. These unfavourable mortality patterns among the unemployed and manual and service and sales workers were especially observed for the more preventable cancers, as we assumed based on the FCT. These occupational inequalities change when other SEP indicators are adjusted for. Multiple SEP indicators should be taken into account when studying SE inequalities in health[@R9] because these allow for different causal pathways.[@R8] Yet, it is difficult to identify to what extent the potential explanatory factors attribute to these inequalities because we do not dispose of data on incidence or survival, nor on data on risk factors, healthcare use or job characteristics. Future studies having access to these kind of data could help to unravel the complex interplay between incidence, survival and mortality and to clarify at which steps the social differences operate.[@R23]

This study can be helpful in providing evidence for policy makers in order to reduce SE inequalities in cancer mortality.[@R37] Our results prove that there is still a long way to go. We observed for example that the unemployed groups are at a much higher risk of dying from cancer compared with the employed population. Ensuring financial security for the unemployed is a key issue in this regard.[@R32] Future research could also study other working regimes, for example, temporary or part-time employment and their relation to health. Finally, there could be an important role for the general practitioner to make sure that the unemployed are getting the healthcare they need.[@R32] Also, for the high-risks jobs, regular health checks at the work floor are needed in order to detect cancers at an early stage.
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